# Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).

> **NCT00795509** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 374 (actual)

## Conditions studied

- Urinary Bladder, Overactive

## Interventions

- **DRUG:** Tolterodine tartrate

## Key facts

- **NCT ID:** NCT00795509
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 374 (ACTUAL)
- **Last updated:** 2012-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00795509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00795509, "Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00795509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*